Cofinimmo SA

ENXTBR:COFB Stock Report

Market Cap: €3.2b

Cofinimmo Future Growth

Future criteria checks 1/6

Cofinimmo's revenue is forecast to decline at 0.6% per annum while its annual earnings are expected to grow at 7.6% per year. EPS is expected to grow by 8.4% per annum. Return on equity is forecast to be 6.9% in 3 years.

Key information

7.6%

Earnings growth rate

8.42%

EPS growth rate

Health Care REITs earnings growth8.7%
Revenue growth rate-0.6%
Future return on equity6.88%
Analyst coverage

Good

Last updated26 May 2026

Recent future growth updates

Recent updates

Narrative Update • May 09

COFB: Aedifica Merger Path And Index Removal Will Shape Balanced Outlook

Analysts have kept their Cofinimmo price target steady at €86.17, citing only small adjustments to the discount rate, revenue growth assumptions, and profit margin forecasts. Their long-term view remains broadly unchanged.
Narrative Update • Apr 25

COFB: Index Removal And 2026 Meeting Will Shape Balanced Risk Profile

Analysts have kept their Cofinimmo price target broadly steady at about €86.17, with the latest update reflecting slightly adjusted assumptions on discount rate, revenue growth and profit margin that leave the implied P/E multiple close to prior levels. What's in the News Cofinimmo SA is recorded as having been removed as an index constituent, which may affect how index funds and ETFs with rules-based mandates treat the stock (Key Developments).
Narrative Update • Apr 10

COFB: Index Exit And Governance Meeting Will Frame Balanced Risk Reward

Analysts have kept their price target for Cofinimmo broadly steady at €86.17. This reflects only marginal tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, rather than any major shift in their view of the shares.
Narrative Update • Mar 27

COFB: Buy Upgrade And Margin Confidence Will Shape Future Risk Reward

Analysts have lifted their price target on Cofinimmo to €86.17 from €86.17. The recent upgrade to Buy supports a slightly more constructive view on its margin profile and long term earnings multiple.
Narrative Update • Mar 10

COFB: Buy Upgrade And Fair Value View Will Frame Future Risk Reward

Analysts have nudged their price target on Cofinimmo higher to €86.17, reflecting updated assumptions on discount rates, a move to modest revenue growth, a slightly lower profit margin, and a higher forward P/E, alongside a recent upgrade to Buy from a major research house. Analyst Commentary Recent research adjustments give you a clearer view of how the market is framing Cofinimmo at the current price target of €86.17 and the revised assumptions on growth, margins, and P/E.
Narrative Update • Feb 24

COFB: Buy Upgrade And Refined Assumptions Will Shape Future Risk Reward Balance

Analysts have nudged their fair value estimate for Cofinimmo higher from about €83.72 to around €86.17, citing updated assumptions on discount rates, revenue trends and future P/E, in line with the recent Buy rating upgrade from Kepler Cheuvreux. Analyst Commentary Bullish Takeaways Bullish analysts see the fair value increase from about €83.72 to around €86.17 as support for the recent rating upgrade, suggesting the current share price offers some valuation headroom relative to their assumptions.
Narrative Update • Feb 10

COFB: Rating Upgrade And Refined Assumptions Will Shape Future Risk Reward Balance

Analysts have modestly adjusted their price targets on Cofinimmo, reflecting slight tweaks to discount rate, revenue growth and profit margin assumptions. Some now see greater upside potential following recent positive research updates and upgrades to Buy.
Narrative Update • Jan 25

COFB: Rating Upgrade And Refined Assumptions Will Support Fair Value

Analysts have nudged their fair value target for Cofinimmo higher from €81.77 to €83.72, citing updated assumptions around discount rates, profit margins and future P/E, alongside recent positive Street research support. Analyst Commentary Recent Street research has taken a more constructive stance on Cofinimmo, reflected in the higher fair value target of €83.72.
Narrative Update • Jan 09

COFB: Rating Upgrade And Stable Cash Flows Will Support Fair Value

Analysts have nudged their fair value estimate for Cofinimmo from €81.41 to €81.77, citing a modestly lower discount rate and slightly refined revenue, margin and future P/E assumptions following recent positive Street research. Analyst Commentary Street research has turned more constructive on Cofinimmo, with some analysts moving to a more positive stance and the fair value estimate edging up to €81.77.
Narrative Update • Dec 26

COFB: Stable Metrics Will Support Fair Value As Risk Perception Slightly Eases

Analysts have trimmed their price target on Cofinimmo slightly to €81.41 from €81.86. This reflects a modestly lower projected future price to earnings multiple and a marginally reduced discount rate in their valuation models.
Narrative Update • Dec 12

COFB: Stable Metrics Will Support Fair Value Amid Slight Profitability Improvement

Narrative Update on Cofinimmo Analysts have modestly raised their price target on Cofinimmo to EUR 81.86, citing a slightly lower implied discount rate and improved projected profit margins, while growth expectations and valuation multiples remain largely unchanged. Valuation Changes Fair Value: Unchanged at €81.86 per share, indicating a stable intrinsic value estimate.
Narrative Update • Nov 27

COFB: Financial Metrics Consistency Will Support Stable Fair Value Outlook

Analysts have maintained their fair value estimate for Cofinimmo at €81.86, citing consistent forecasted financial metrics and only minimal updates to underlying assumptions. Valuation Changes Fair Value Estimate remains unchanged at €81.86.
Narrative Update • Nov 11

COFB: Revenue and Profit Margin Trends Will Shape Fair Value Outlook

Analysts have slightly increased their price target for Cofinimmo from €80.92 to €81.86. They cite improved revenue growth projections and a marginally lower discount rate as key factors behind the adjustment.
User avatar
New Narrative • May 16

Healthcare Real Estate Shift Will Yield Lasting Value

Strategic focus on healthcare real estate and divesting non-core areas aims to improve revenue and optimize net margins.
Analysis Article • Feb 11

Shareholders Of Cofinimmo (EBR:COFB) Must Be Happy With Their 64% Return

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...

Earnings and Revenue Growth Forecasts

ENXTBR:COFB - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202838225589N/A3
12/31/2027369237105N/A7
12/31/2026356229123N/A2
3/31/2026383203N/AN/AN/A
12/31/2025382213297297N/A
9/30/2025390192N/AN/AN/A
6/30/2025391134288288N/A
3/31/2025392111N/AN/AN/A
12/31/202439264279279N/A
9/30/2024392-52N/AN/AN/A
6/30/2024392-41254255N/A
3/31/2024391-55N/AN/AN/A
12/31/2023389-55227228N/A
9/30/202337949N/AN/AN/A
6/30/2023379185223224N/A
3/31/2023373333N/AN/AN/A
12/31/2022368483209210N/A
9/30/2022367565N/AN/AN/A
6/30/2022357489205206N/A
3/31/2022351382N/AN/AN/A
12/31/2021343260199200N/A
9/30/2021328189N/AN/AN/A
6/30/2021312155185186N/A
3/31/2021276122N/AN/AN/A
12/31/2020293119178180N/A
9/30/2020296170N/AN/AN/A
6/30/2020266193166167N/A
3/31/2020292222N/AN/AN/A
12/31/2019285205N/A169N/A
9/30/2019241134N/AN/AN/A
6/30/2019270119N/A182N/A
3/31/2019259105N/AN/AN/A
12/31/2018263146N/A161N/A
9/30/2018260186N/AN/AN/A
6/30/2018258170N/A140N/A
3/31/2018264166N/AN/AN/A
12/31/2017263137N/A157N/A
9/30/2017267121N/AN/AN/A
6/30/2017267128N/A168N/A
3/31/2017275134N/AN/AN/A
12/31/201625797N/A144N/A
9/30/2016253100N/AN/AN/A
6/30/201625582N/A148N/A
3/31/2016249110N/AN/AN/A
12/31/2015255104N/A170N/A
9/30/201526076N/AN/AN/A
6/30/201526266N/A158N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: COFB's forecast earnings growth (7.6% per year) is above the savings rate (2.4%).

Earnings vs Market: COFB's earnings (7.6% per year) are forecast to grow slower than the Belgian market (13.2% per year).

High Growth Earnings: COFB's earnings are forecast to grow, but not significantly.

Revenue vs Market: COFB's revenue is expected to decline over the next 3 years (-0.6% per year).

High Growth Revenue: COFB's revenue is forecast to decline over the next 3 years (-0.6% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: COFB's Return on Equity is forecast to be low in 3 years time (6.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/26 12:59
End of Day Share Price 2026/05/26 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cofinimmo SA is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Celine HuynhBarclays
Kai KloseBerenberg
Robert JonesBNP Paribas